2Beamer NB, Coull BM, Clark WM, et al. Inerleukin - 6 and inter- leukin- 1 receptor antagonist in acute stroke[J]. Ann Neurol, 1995, 37(6) :800- 805.
3Yamasaki Y, Matsaura N, Shozuhara H, et al. Interleukin - 1 as a pat hosenetic mediator of ischemic brain damage in rats [ J ]. Stroke, 1995, 25 : 676.
4Farkas G, Matron J, Nagy I, et al. Experinental acute pancreatitis results un uncreasd blood - brain barrier permeability in the rateapotential role for tumor necrosis factor and inerleukin- 6 [ J ]. Neurosci Lett, 1998, 242:147.
5Fassbender K, Rssol S, Kammer T, et al. Proinflammatory cy- tokines in serum of patients with acute cerebral ischemic kinetics of secretion and relation to the extent of brain damage and out- come of disease[J]. Neyrik Sci, 9194, 12:135.
6Jeon GS, Park SK, Park SW, et al. Glial expression of interleukin - 18 and ies receptor after excitotoxic damage in the mouse hip- pocampus[J ]. Neurocem Res, 2008, 33(1) : 179 - 184.
7Felderhoff MU, Schdidt OI, Oberholer A, et al. IL - 18: a key player in neuroinflarnmation and neurodegeneration [ J ]. Trends Neurosci, 2005, 28(9) :487 - 493.
8Peroulis N, Kourounakis AP, Yiangou M, et al. Effects of the nov- el non- steroidal anti - inflammatory compound. (Z - thiolethyl) - 2 - 2 - [ N - ( 2, 6 - dichlorophenyl) amino] phenyl acetamide on cytokines and apoptosis in ischemic rat brain[J ]. Adrzneimit- telforschung, 2006, 56(10) :688 - 694.
10T Ninomiya,M Kubo,Y Doi.Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population:the Hisayama study[J].Stroke,2007,38(7):2063-2069.
